Accessibility: Skip TopNav
Matinas' Positivein vivo Safety Data with its Oral LNC-Docetaxel Formulation
Oral LNC-Docetaxel is significantly less toxic than IV-Docetaxel
Format
JPEG
Source
Matinas BioPharma Holdings, Inc.
Downloads
Original
Large
Medium
Small